KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $199.2 billion.

  • Johnson & Johnson's Liabilities and Shareholders Equity rose 1060.83% to $199.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $779.1 billion, marking a year-over-year increase of 950.76%. This contributed to the annual value of $199.2 billion for FY2025, which is 1060.83% up from last year.
  • According to the latest figures from Q4 2025, Johnson & Johnson's Liabilities and Shareholders Equity is $199.2 billion, which was up 1060.83% from $192.8 billion recorded in Q3 2025.
  • In the past 5 years, Johnson & Johnson's Liabilities and Shareholders Equity registered a high of $199.2 billion during Q4 2025, and its lowest value of $166.1 billion during Q4 2023.
  • Over the past 5 years, Johnson & Johnson's median Liabilities and Shareholders Equity value was $179.2 billion (recorded in 2021), while the average stood at $181.7 billion.
  • Per our database at Business Quant, Johnson & Johnson's Liabilities and Shareholders Equity tumbled by 1224.84% in 2024 and then skyrocketed by 1262.17% in 2025.
  • Over the past 5 years, Johnson & Johnson's Liabilities and Shareholders Equity (Quarter) stood at $179.2 billion in 2021, then decreased by 2.29% to $175.1 billion in 2022, then dropped by 4.32% to $167.6 billion in 2023, then increased by 7.49% to $180.1 billion in 2024, then grew by 10.61% to $199.2 billion in 2025.
  • Its Liabilities and Shareholders Equity was $199.2 billion in Q4 2025, compared to $192.8 billion in Q3 2025 and $193.4 billion in Q2 2025.